BioMarin Pharmaceutical, Inc. (BMRN)
54.13
-0.90
(-1.64%)
USD |
NASDAQ |
Mar 20, 16:00
54.01
-0.12
(-0.22%)
After-Hours: 20:00
BioMarin Pharmaceutical Research and Development Expense (Quarterly) : 192.41M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 23.74M |
| Ionis Pharmaceuticals, Inc. | 279.36M |
| Mirum Pharmaceuticals, Inc. | 51.03M |
| MannKind Corp. | 27.59M |
| Terns Pharmaceuticals, Inc. | 19.92M |